The role of RICTOR downstream of receptor tyrosine kinase in cancers - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Molecular Cancer Année : 2018

The role of RICTOR downstream of receptor tyrosine kinase in cancers

Résumé

AbstractThe importance of the network defined by phosphatidylinositol-3-kinase (PI3K), AKT and mammalian target of rapamycin (mTOR) downstream of Receptor Tyrosine Kinase (RTK) has been known for many years but the central role of RICTOR (rapamycin-insensitive companion of mTOR) in this pathway is only starting to emerge. RICTOR is critical for mTORC2 (the mammalian target of rapamycin complex 2) kinase activity and as such plays a key role downstream of RTK. Alterations of RICTOR have been identified in a number of cancer cell types and its involvement in tumorigenesis has begun to be unraveled recently. Here, we summarize new research into the biology of RICTOR signaling in cancers focusing on tumors with altered RTK. We show that, as a key signaling node and critical effector of RTKs, RICTOR is becoming a valuable therapeutic target in cancer with altered RTK.
Fichier principal
Vignette du fichier
12943_2018_Article_794.pdf (1.16 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-01716891 , version 1 (25-02-2018)

Identifiants

Citer

Ahlem Jebali, Nicolas Dumaz. The role of RICTOR downstream of receptor tyrosine kinase in cancers. Molecular Cancer, 2018, 17 (1), pp.39. ⟨10.1186/s12943-018-0794-0⟩. ⟨inserm-01716891⟩
40 Consultations
127 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More